Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Translational Medicine @ Unisa|August 5, 2017
EGFR Inhibition in a Pretreated Sacral Chordoma: A Role for Erlotinib? Case Report and a Brief Review of LiteratureD Trapani, F Conforti, T De Pas
British Journal of Cancer|October 17, 2003
Imatinib administration in two patients with liver metastases from GIST and severe jaundiceT De Pas, R Danesi, C Catania, et al.
Critical Reviews in Oncology/Hematology|March 29, 2000
Ifosfamide in the elderly: clinical considerations for a better drug managementT De Pas, G Curigliano, C Catania, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Gemcitabine-induced systemic capillary leak syndromeT De Pas, G Curigliano, L Franceschelli, et al.
British Journal of Cancer|March 6, 2003
Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma GroupT De Pas, L Bodei, G Pelosi, et al.
American Journal of Clinical Oncology|June 17, 1998
Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracilF deBraud, E Munzone, F Nolè, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancerS Fogli, R Danesi, F De Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2015
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumorsF de Braud, S Cascinu, G Spitaleri, et al.
Anticancer Research|February 19, 2002
GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysisG Curigliano, G Ferretti, M Mandalà, et al.
ESMO Open|August 29, 2021
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trialsF Conforti, L Pala, E Pagan, et al.
Pageof 4